Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000143875 | SCV000050856 | likely benign | Hypertrophic cardiomyopathy | 2018-04-05 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037780 | SCV000061442 | uncertain significance | not specified | 2012-03-06 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The Arg100His varia nt (CSRP3) has been reported in 1 individual with HCM (Anderson 2009) and has be en detected in 1 individual with HCM tested by our laboratory who carried a path ogenic HCM variant (LMM unpublished data). This variant has been identified in 0.1% (6/7020) of European American chromosomes from a broad population by the NH LBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs13821852 3). While this frequency suggests that it is more likely benign but it is too lo w to confidently rule out a disease causing role. Additional information is need ed to fully assess its clinical significance. |
Blueprint Genetics | RCV000037780 | SCV000188744 | benign | not specified | 2015-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514222 | SCV000235770 | likely benign | not provided | 2020-07-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23299917, 24082139, 19035361, 23861362, 30012424) |
Invitae | RCV001087554 | SCV000253397 | benign | Hypertrophic cardiomyopathy 12; Dilated cardiomyopathy 1M | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514222 | SCV000610652 | likely benign | not provided | 2017-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617191 | SCV000736682 | likely benign | Cardiovascular phenotype | 2019-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000037780 | SCV001157233 | likely benign | not specified | 2019-04-07 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001107280 | SCV001264421 | uncertain significance | Hypertrophic cardiomyopathy 12 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
CHEO Genetics Diagnostic Laboratory, |
RCV001170413 | SCV001332990 | benign | Cardiomyopathy | 2018-05-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037780 | SCV002014940 | likely benign | not specified | 2021-10-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003934915 | SCV004756440 | likely benign | CSRP3-related condition | 2020-09-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000514222 | SCV001743846 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000514222 | SCV001918319 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000514222 | SCV001956985 | likely benign | not provided | no assertion criteria provided | clinical testing |